Contribute Try STAT+ Today

Pharma

Taking stock of the drug industry, from the lab to the medicine chest. For a weekly update, sign up for our free Pharmalot newsletter. And subscribe to STAT+ for exclusive coverage and analysis of the pharma industry — from drug pipelines to boardroom shakeups.

Pharma By Matthew Herper

What we know — and don’t know — about Merck’s new Covid-19 pill

STAT looks at the unanswered questions about Merck's new Covid-19 drug, molnupiravir, and about other Covid-fighting pills in development.

OC Phases

Exclusive By Shraddha Chakradhar and Casey Ross

The history of OxyContin, told through unsealed Purdue documents

Prescription Politics By Lev Facher

More than two-thirds of Congress cashed a pharma campaign check in 2020, new STAT analysis shows

Porous Silica Nanoparticles

Biotech By Elizabeth Cooney

How nanotechnology helps mRNA Covid-19 vaccines work

Pharmalot By Ed Silverman

Pharmalittle: FDA scientists uncertain about Moderna vaccine boosters; pharma may face stricter rules for supplying meds in the EU

All Coverage

Pharmalot By Ed Silverman

Pharmalittle: Most Americans support Medicare drug price negotiations; Moderna refuses to share its Covid-19 vaccine secret sauce

Pharmalot Coming/Going STILL

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

advertisement

Pharmalot By Damian Garde

Pharmalittle: How COVAX failed on its promise to vaccinate the world; White House close to picking FDA nominee

Humira injection

Pharma By Ed Silverman

AbbVie loses a lawsuit over Humira trade secrets it claimed were stolen

Covid Clinical Trials

Pharmalot By Ed Silverman

Europe’s largest clinical trial sponsors are getting better at reporting results

John Yang Moderna 2

Pharmalot By Ed Silverman

Moderna plans a vaccine plant in Africa, but critics say the move isn’t enough to ensure access

Pharmalot By Ed Silverman

Pharmalittle: White House and Moderna battle over global vaccine donations; Pfizer seeks FDA OK for kids to get its Covid shot

Pharmalot By Ed Silverman

Older Americans bore the brunt of antibiotic-resistant infections, study finds

Pharmalot By Ed Silverman

Pharmalittle: Henrietta Lacks estate plans to sue more companies; Sweden halts Moderna Covid shot for people 30 and younger

AstraZeneca signage

Pharmalot By Ed Silverman

AstraZeneca to pay $560,000 to settle claims of discriminating against women sales reps

Pharmalot By Ed Silverman

Pharmalittle: Francis Collins to step down as NIH director; Research confirms decline in Pfizer vaccine protection against ‘breakthrough’ infection

Pharmalot By Ed Silverman

Merck’s Covid-19 pill may be a game-changer, but questions are already being raised about cost

Pharmalot By Ed Silverman

Pharmalittle: J&J to seek emergency use of Covid-19 vaccine booster; Pfizer loses legal battle over Medicare co-pay programs

Scorecard

Biotech By Adam Feuerstein

The biotech scorecard for the fourth quarter: 19 stock-moving events to watch

Bribery

Pharmalot By Ed Silverman

Pfizer loses a lawsuit alleging the U.S. illegally limits use of patient copay assistance programs

opioid settlement

Pharmalot By Ed Silverman

Three generic drug makers to pay $450 million to settle civil price fixing charges

Pill world map public-private partnership

Pharmalot By Ed Silverman

For the first time, WHO committee recommends action on high-priced essential medicines

Pharmalot Coming/Going STILL

Pharmalot By Ed Silverman

Up and down the ladder: The latest comings and goings

Pharmalot By Ed Silverman

Pharmalittle: Merck’s Covid-19 pill reduced hospitalizations in a study; Dems start scaling back drug-pricing plans

FDA sign FDA commissioner

Pharmalot By Ed Silverman

Appeals court rules FDA ‘arbitrarily and capriciously’ approved a rare disease drug

Pharmalot By Ed Silverman

Pharmalittle: House panel OKs bills to halt pharma practices that raise prices; Merck to buy Acceleron for $11.5 billion

Pharmalot By Ed Silverman

Pharmalittle: Run on ivermectin tablets leaves less for livestock; Pfizer Covid-19 shot for kids may not come until November

Purdue Pharma gate

Pharmalot By Ed Silverman

As lawsuits mounted, Purdue cultivated conversations with a controversial addiction policy group

Pharmalot By Ed Silverman

Lilly cuts the wholesale price on some insulin products, but impact is likely to be limited